Holen Sie sich die Stockscreener-App
2.09
6.23%
0.11
Tenax Therapeutics Inc Aktie (TENX) Neueste Nachrichten
Tenax at Cantor conference: trial miss sharpens next-step strategy By Investing.com - Investing.com India
Adar1 Capital Management, 10% owner, buys $1.6m in Tenax Therapeutics By Investing.com - Investing.com South Africa
Adar1 Capital Management, 10% owner, buys $1.6m in Tenax Therapeutics - Investing.com Canada
ADAR1 Capital Management, LLC Expands Tenax Therapeutics Inc (TENX) Stake in Strategic Add - GuruFocus
One manager just reported a 14% holding in Tenax Therapeutics (TENX) - Stock Titan
FMR LLC reports 514,925-share stake in Tenax (NASDAQ: TENX) - Stock Titan
TENX Jumps As Tenax Therapeutics Pivots Phase 3 Strategy - timothysykes.com
Tenax Therapeutics Stock Wobbles After Mixed Phase 3 Data - timothysykes.com
Tenax Therapeutics Inc (NASDAQ: TENX) Share Price, TENX Stock News, TENX Share Price & Updates - Kalkine
Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable? - finance.yahoo.com
Sphera Funds Management Boosts Tenax Therapeutics Stake in High-Risk Biotech Bet - GuruFocus
Investment funds tied to Tenax (TENX) 10% owner just bought more stock - Stock Titan
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - Stock Titan
TENX Downgraded by Guggenheim -- Rating Updated to Neutral - GuruFocus
Piper Sandler Maintains Tenax Therapeutics(TENX.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Guggenheim Downgrades TENX to Neutral Amid Uncertain Clinical Ou - GuruFocus
Why is Tenax Therapeutics stock volatile today? By Investing.com - Investing.com Canada
Tenax Therapeutics (TENX) Phase 3 Data Spurs Focus on Subgroup B - GuruFocus
Tenax finds benefit in sicker patient subgroup after Phase 3 trial miss (TENX:NASDAQ) - Seeking Alpha
Tenax presents additional Phase 3 trial data for TNX-103 By Investing.com - Investing.com Nigeria
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 - Investing News Network
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL - GlobeNewswire
ING Groep reveals passive stake in Tenax Therapeutics (ING) - Stock Titan
New 5.3% backer emerges in Tenax Therapeutics (NASDAQ: TENX) - Stock Titan
Tenax Therapeutics Stock (TENX) Opinions on Recent Insider Purchases and Gains - quiverquant.com
Tenax rises on over $1.8M insider buying (TENX:NASDAQ) - Seeking Alpha
ADAR1 Capital Management, LLC Expands Tenax Therapeutics Inc (TE - GuruFocus
Adar1 Capital Management buys $1.8m of Tenax Therapeutics (TENX) shares - Investing.com Canada
Millennium Management Boosts Tenax Therapeutics Stake Despite St - GuruFocus
Price to book forward of Tenax Therapeutics, Inc. – HAM:YBO0 - TradingView
Enterprise value of Tenax Therapeutics, Inc. – HAM:YBO0 - TradingView
Total revenue of Tenax Therapeutics, Inc. – HAM:YBO0 - TradingView
RTW Investments, LP Expands Tenax Therapeutics (TENX) Stake Desp - GuruFocus
Tenax Therapeutics (TENX) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Israel Englander funds hold over 5% of Tenax Therapeutics (TENX) - Stock Titan
TENX Q2 2026 Earnings: Narrower Loss Per Share Fails to Offset Stock DeclineEPS Revision Trend - vinanet.vn
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Tenax Therapeutics (TENX) - GlobeNewswire
TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law - The AI Journal
Price-Driven Insight from (TENX) for Rule-Based Strategy - Stock Traders Daily
symbol__ Stock Quote Price and Forecast - CNN
Tenax Therapeutics (NASDAQ:TENX) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat
Ikarian Capital (TENX) discloses 2.9% beneficial stake in Tenax Therapeutics common stock - Stock Titan
Venrock group (TENX) discloses 1.57M-share warrant-based stake in Tenax - Stock Titan
Perceptive Advisors (TENX) reports beneficial ownership of 1.7M Tenax Therapeutics shares - Stock Titan
Tenax Therapeutics (TENX) holder BVF reports 3.11M shares, big warrant overhang - Stock Titan
Vivo Opportunity discloses 9% Tenax Therapeutics (TENX) holding via stock and warrants - Stock Titan
TENX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Tenax Therapeutics (TENX) - Business Wire
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
RTW Investments discloses 9.99% Tenax Therapeutics (TENX) position with 2.87M shares - Stock Titan
Tenax Therapeutics (TENX) Rallies 6.4% to $1.83, Approaching Key ResistanceNarrow Range Breakout - Vinanet
TENX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Tenax Therapeutics - Morningstar
Piper Sandler Maintains Tenax Therapeutics(TENX.US) With Buy Rating, Cuts Target Price to $14 - Moomoo
Tenax Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Tenax Therapeutics (TENX) - Morningstar
Adage Capital discloses 6.81% Tenax Therapeutics (TENX) stake via stock and warrants - Stock Titan
Tenax Therapeutics Is Maintained at Buy by Canaccord Genuity - Moomoo
Tenax Therapeutics downgraded to Neutral after ... - Pluang
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):